Distortion product otoacoustic emission findings in Behcet's disease and rheumatoid arthritis

被引:17
作者
Bayazit, Yildirim A. [1 ]
Yilmaz, Metin
Gunduz, Bulent
Altinyay, Senay
Kemaloglu, Yusuf K.
Onder, Meltem
Gurer, Mehmet Ali
机构
[1] Gazi Univ, Fac Med, Dept Otolaryngol, Ankara, Turkey
[2] Gazi Univ, Fac Med, Dept Dermatol, Ankara, Turkey
[3] Gazi Univ, Fac Med, Dept Audiol, Prof Dr N Akyildiz Hearing Balance & Speech Ctr, Ankara, Turkey
来源
ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES | 2007年 / 69卷 / 04期
关键词
Behcet's disease; rheumatoid arthritis; otoacoustic emission;
D O I
10.1159/000101544
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background and Objective: This study aimed to assess cochlear functions in Behcet's disease and rheumatoid arthritis (RA) using otoacoustic emission testing (OAE), which objectively assesses outer hair cells in the cochlea. Methods: Patients with Behcet's disease (n = 16) and RA (n = 11) as well as 20 controls were tested using pure tone audiometry and transiently evoked (TEOAEs) and distortion product OAEs (DPOAEs). Results: Pure tone results in the Behcet's group were not significantly different from controls (p > 0.05). Pure tone results in the RA group were significantly different than in controls at 250, 500 and 6,000 Hz (p < 0.05). TEOAEs could be obtained in all participants. DPOAE amplitudes in the RA group and controls were similar (p > 0.05). DPOAE amplitudes were significantly higher in the Behcet's group than in controls at 1 and 2 kHz (p < 0.05). Conclusion: A subtle deterioration in hearing can be seen at low and high frequencies in RA, which is not related to outer hair cell dysfunction as detected by DPOAE testing. In the patients with Behcet's disease who have hearing thresholds within the normal limits, outer hair cell functions seem spared with an increased activity in the apical regions of the cochlea. (C) 2007 S. Karger AG, Basel.
引用
收藏
页码:233 / 238
页数:6
相关论文
共 39 条
[1]  
Adler YD, 2002, CLIN EXP RHEUMATOL, V20, pS40
[2]   Neurotological status in Behcet's disease and its ophthalmological correlates [J].
Bayazit, YA ;
Evereklioglu, C ;
Ozer, E ;
Kirtak, N ;
Bayazit, N ;
Kanlikama, M ;
Inalöz, S .
POSTGRADUATE MEDICAL JOURNAL, 2004, 80 (950) :724-728
[3]  
Belkahia A, 1982, Ann Otolaryngol Chir Cervicofac, V99, P469
[4]  
BRAMA I, 1980, ARCH OTOLARYNGOL, V106, P215
[5]  
COLLETTI V, 1997, RHEUMATOL INT, V22, P16
[6]   EFFECT OF CYCLOSPORINE-A ON THE HEARING-LOSS IN BEHCETS-DISEASE [J].
ELIDAN, J ;
COHEN, E ;
LEVI, H ;
BENEZRA, D .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1991, 100 (06) :464-468
[7]  
ELWANY S, 1986, J RHEUMATOL, V13, P878
[8]   Exploration of the early auditory effects of hyperlipoproteinemia and diabetes mellitus using otoacoustic emissions [J].
Erdem, T ;
Ozturan, O ;
Miman, MC ;
Ozturk, C ;
Karatas, E .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2003, 260 (02) :62-66
[9]  
Erdinc AK, 2004, AURIS NASUS LARYNX, V31, P29
[10]  
Evereklioglu C, 2001, J LARYNGOL OTOL, V115, P704